Regressed coronary ostial stenosis in a young female with Takayasu arteritis: a case report.
Adolescent
Adrenal Cortex Hormones
/ therapeutic use
Antibodies, Monoclonal, Humanized
/ therapeutic use
Coronary Stenosis
/ diagnostic imaging
Drug Therapy, Combination
Female
Humans
Immunosuppressive Agents
/ therapeutic use
Prednisolone
/ therapeutic use
Remission Induction
Takayasu Arteritis
/ complications
Treatment Outcome
18F-fluorodeoxyglucose positron emission tomography/computed tomography
Case report
Coronary ostial stenosis
Regression
Takayasu arteritis
Tocilizumab
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
02 04 2019
02 04 2019
Historique:
received:
02
12
2018
accepted:
24
03
2019
entrez:
4
4
2019
pubmed:
4
4
2019
medline:
28
1
2020
Statut:
epublish
Résumé
Takayasu arteritis is a rare systemic vasculitis, which affects the aorta and its major branches, especially in young females. Diagnosis and treatment for Takayasu arteritis with coronary stenosis are important to prevent fatal complications. Immunosuppressive treatment such as corticosteroid is a common treatment for this condition. However, the effects of immunosuppressive treatment on inflammatory coronary stenosis caused by Takayasu arteritis remains unknown. An 18-year-old female had chest oppression on effort and was referred to our hospital due to ST-segment depression in I, aV We described regressed coronary ostial stenosis in a young female patient with Takayasu arteritis. Immunosuppressive treatment might have a favorable effect on coronary ostial stenosis in Takayasu arteritis.
Sections du résumé
BACKGROUND
Takayasu arteritis is a rare systemic vasculitis, which affects the aorta and its major branches, especially in young females. Diagnosis and treatment for Takayasu arteritis with coronary stenosis are important to prevent fatal complications. Immunosuppressive treatment such as corticosteroid is a common treatment for this condition. However, the effects of immunosuppressive treatment on inflammatory coronary stenosis caused by Takayasu arteritis remains unknown.
CASE PRESENTATION
An 18-year-old female had chest oppression on effort and was referred to our hospital due to ST-segment depression in I, aV
CONCLUSIONS
We described regressed coronary ostial stenosis in a young female patient with Takayasu arteritis. Immunosuppressive treatment might have a favorable effect on coronary ostial stenosis in Takayasu arteritis.
Identifiants
pubmed: 30940076
doi: 10.1186/s12872-019-1066-7
pii: 10.1186/s12872-019-1066-7
pmc: PMC6446325
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Antibodies, Monoclonal, Humanized
0
Immunosuppressive Agents
0
Prednisolone
9PHQ9Y1OLM
tocilizumab
I031V2H011
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
79Références
Rheumatol Int. 2017 Oct;37(10):1643-1649
pubmed: 28801814
JACC Cardiovasc Imaging. 2012 Apr;5(4):422-9
pubmed: 22498333
Br Heart J. 1974 Jan;36(1):114-6
pubmed: 4818136
Jpn J Thorac Cardiovasc Surg. 2000 Sep;48(9):594-6
pubmed: 11030134
Stroke. 1987 May-Jun;18(3):677-9
pubmed: 2884760
Q J Med. 1964 Jan;33:57-69
pubmed: 14116856
J Thorac Cardiovasc Surg. 1991 Oct;102(4):554-60
pubmed: 1681139
J Nucl Cardiol. 2020 Feb;27(1):333-335
pubmed: 30238297
Circulation. 2015 Nov 3;132(18):1693-700
pubmed: 26354797
Pediatr Rheumatol Online J. 2013 Feb 12;11(1):4
pubmed: 23398983
Lancet. 2000 Sep 16;356(9234):1023-5
pubmed: 11041416
Medicine (Baltimore). 2018 Oct;97(41):e12637
pubmed: 30313050
Circulation. 2012 Feb 14;125(6):813-9
pubmed: 22230484
Rheumatol Int. 2010 Feb;30(4):561-3
pubmed: 20020137
Circ J. 2012;76(4):1004-11
pubmed: 22301847
Semin Arthritis Rheum. 2017 Oct;47(2):247-252
pubmed: 28457530
Heart. 2018 Apr;104(7):558-565
pubmed: 29175979
Circ J. 2005 Jun;69(6):752-5
pubmed: 15914957
S Afr Med J. 1980 Jan 19;57(3):96-8
pubmed: 6105718
Circulation. 1985 Feb;71(2):280-8
pubmed: 3965172